Semaglutide Injection — lifestyle
    INJECTION

    Semaglutide Injection

    For the men who want fat loss and an appetite reset — without watching hard-won muscle go with it.

    • Lower appetite and fewer cravings
    • Fat loss, formulated to protect muscle
    • A once-weekly injection, not a daily routine
    $229/moFree shipping
    Start Your Protocol

    Next: brief medical assessment, then physician review. Usually within 24 hours.

    Cancel or pause anytime.

    US board-certified physician review

    A board-certified physician builds your protocol.

    US-licensed 503A pharmacy

    Pharmaceutical-grade purity, prescribed by your physician.

    Shipped discreetly to your door

    Subscription billed monthly. Cancel anytime.

    How Semaglutide works

    Semaglutide is a GLP-1 receptor agonist — it acts on the brain's appetite signals and the hormones that regulate blood sugar.

    Semaglutide is a GLP-1 analog — a close structural match to glucagon-like peptide-1 (GLP-1), an incretin hormone the body releases naturally after eating. By activating the GLP-1 receptor, semaglutide increases insulin production, lowers glucagon secretion, and acts on the regions of the brain that regulate appetite and food intake.

    The GLP-1 the body produces on its own lasts only minutes. A small structural change to the semaglutide molecule extends that to weeks, which is what makes a once-weekly protocol possible. Semaglutide is not insulin and not a stimulant — it works through the body's own appetite and glucose-regulation systems rather than overriding them.

    EdgeRx's semaglutide is compounded with two deliberate additions. Glycine, an amino acid, is included because research on calorie restriction suggests it may help limit the breakdown of muscle protein during weight loss — preserving lean mass, not just lowering the number on the scale. Vitamin B12 (cyanocobalamin) is included to support nutrient repletion during a period of reduced food intake, and may help reduce the nausea that can accompany the early weeks of a GLP-1 protocol.

    Why Semaglutide

    Semaglutide became a household name faster than the healthcare system adapted to it. Branded GLP-1s sit behind insurance criteria, supply constraints, and pricing built around a diabetes diagnosis. A standard care visit often will not prescribe one for body composition without meeting those thresholds. Most men researching semaglutide find the compound long before they find a physician who will prescribe and manage it.

    EdgeRx closes that gap — a compounded semaglutide protocol, formulated with muscle-preserving glycine and B12, prescribed and titrated by a US board-certified physician who reviews your history first. The protocol is built around male body composition, not a number on a scale.

    What to expect

    Semaglutide is titrated: your physician starts you at a low dose and steps it up over time, which is how the protocol limits side effects while your body adjusts. Most men notice reduced appetite and fewer cravings within the first few weeks. Changes in body composition build gradually over the months that follow. This is a sustained protocol, not a short course.

    • Lower appetite and fewer cravings, without leaning on willpower
    • Gradual, sustained fat loss — not a crash
    • A protocol built to help you hold onto lean mass, not just lose weight
    • Less of the constant background pull toward food

    What Semaglutide supports

    Appetite regulation

    Semaglutide acts on the regions of the brain that regulate appetite and food intake. By engaging the GLP-1 receptor, it can lower hunger signals and reduce cravings — the mechanism behind the smaller appetite most men report.

    Blood sugar response

    Semaglutide increases glucose-dependent insulin production and lowers glucagon secretion. This supports a steadier blood sugar response to meals, one part of the metabolic picture a physician evaluates alongside body composition.

    Muscle preservation

    EdgeRx's formulation includes glycine, an amino acid studied for its role in limiting the breakdown of muscle protein during calorie restriction. Holding on to lean mass while losing fat is the body composition outcome that defines a protocol built for men.

    Nutrient support

    Vitamin B12 is compounded into the protocol to support nutrient repletion during a period of reduced food intake, and may help mitigate the nausea that can accompany the early weeks of GLP-1 use.

    How you take it

    The routine

    A once-weekly subcutaneous injection — given just under the skin, not into muscle, with an insulin-sized needle. It ships as a ready-to-use solution: no mixing and no reconstitution. You draw the dose your physician has set and inject it on the same day each week.

    Starting dose

    Your physician sets your starting dose and your titration schedule from your medical history. Semaglutide protocols begin low and step up gradually — a deliberate pace that gives your body time to adjust and keeps side effects like nausea manageable. The protocol is supplied in variable-dose vials, so your physician can fine-tune each step without changing the formulation. Most men begin at the lowest dose and move up at physician check-ins.

    Schedule

    Semaglutide protocols are run as ongoing metabolic support, not as a short course. After the titration period, your physician sets a maintenance approach based on your progress — continuing, holding, or adjusting the dose over time. There is no fixed end date; the schedule is a clinical decision your physician revisits at your check-ins.

    Questions

    No. Ozempic and Wegovy are FDA-approved finished products — manufactured, tested, and reviewed by the FDA for safety and effectiveness. EdgeRx's protocol is a compounded preparation made by a US-licensed 503A pharmacy for an individual patient on a physician's prescription, and formulated with glycine and B12. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality, and they are not a generic, substitute, or equivalent for any branded product. Your physician determines whether a compounded semaglutide protocol is appropriate for you.

    Semaglutide is available through 503A compounding pharmacies in the US, where it is prepared under FDA-regulated quality standards by US-licensed pharmacies. Compounded medications are not reviewed or approved by the FDA as finished products. They are prepared for an individual patient on the basis of a physician's prescription.

    Significant weight loss reduces fat, and without attention to it, some lean muscle as well. Glycine is an amino acid studied for its role in limiting the breakdown of muscle protein during calorie restriction; it is included to support muscle preservation while you lose fat. Vitamin B12 supports nutrient repletion during a period of reduced food intake and may help reduce early nausea. Together, they are why EdgeRx's protocol is built around body composition rather than weight loss alone.

    Both are once-weekly GLP-1 injections formulated with glycine and B12. Semaglutide acts on the GLP-1 receptor alone, while tirzepatide is a dual agonist that activates both the GLP-1 and GIP receptors. Men and their physicians often consider semaglutide as a starting GLP-1 protocol and tirzepatide as a step up, but that is a clinical decision: your physician recommends one based on your history, your goals, and how you respond. Either protocol is titrated and physician-managed.

    Semaglutide should not be combined with any other GLP-1 medication, including tirzepatide, and your physician screens for this. Beyond that, many men run a metabolic protocol alongside protocols from other categories. The protocol your physician builds accounts for everything else you are taking, so disclose your full medication list during the medical assessment.

    The most common side effects are gastrointestinal: nausea and constipation most often, and sometimes acid reflux, stomach pain, vomiting, diarrhea, or a reaction at the injection site. They tend to be most noticeable in the early weeks and as the dose steps up, which is why the protocol is titrated gradually. The risk of more serious effects is higher in men with hypoglycemia, kidney problems, or a history of allergic reactions. Your physician reviews your risk before prescribing and adjusts the protocol if side effects are hard to tolerate.

    Semaglutide is not appropriate for everyone. It should not be used by anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and it is not for use during pregnancy or breastfeeding. It is not insulin and is not a treatment for type 1 diabetes. Men with a history of pancreatitis, kidney problems, or diabetic retinopathy need careful physician evaluation first. Because semaglutide slows stomach emptying, tell any provider about your protocol before a planned surgery or procedure involving anesthesia or sedation. Your physician screens for all of this during the medical assessment.

    Most men notice reduced appetite and fewer cravings within the first few weeks. Visible changes in weight and body composition come more gradually, over months, as the dose is titrated up and the protocol settles into a maintenance range. Semaglutide is a sustained protocol: the results come from consistent use over time, not from any single injection.

    Also consider

    INJECTION

    Tirzepatide Injection

    $299/mo

    A dual-receptor GLP-1 protocol, often the next step up

    INJECTION

    MICC Lipotropic Injection

    $49/mo

    A lipotropic injection for metabolic support, without a GLP-1

    Start the Semaglutide protocol

    Brief medical assessment. US board-certified physician review. Shipped from a US-licensed pharmacy.

    Start Your Protocol

    Semaglutide Injection is a compounded medication prepared by a US-licensed 503A compounding pharmacy under FDA-regulated quality standards. Compounded medications are not FDA-approved as finished products. A prescription is determined by a US board-certified physician after a brief medical assessment, and not all patients are eligible. Semaglutide should not be used by anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, during pregnancy or breastfeeding, or in combination with another GLP-1 medication. It is not insulin and is not a treatment for type 1 diabetes. Tell your physician about any history of pancreatitis, kidney problems, or diabetic retinopathy, and inform any provider before a surgery or procedure involving anesthesia. Your physician reviews your full medical history before prescribing.

    Find a different protocol